-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HfvWSljDJSuf6DAYzlD8N8Xv/Ef67CxOp1/iOMQyxdrigqQ5qhKhV9nRHzFoT4Fe zUgTArvlvnjenhFzCIjPcg== 0001104659-09-013954.txt : 20090303 0001104659-09-013954.hdr.sgml : 20090303 20090303192418 ACCESSION NUMBER: 0001104659-09-013954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090302 FILED AS OF DATE: 20090303 DATE AS OF CHANGE: 20090303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIDSON EUGENE A CENTRAL INDEX KEY: 0001250757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 09653440 MAIL ADDRESS: STREET 1: 5506 NEBRASKA AVE NW CITY: WASHINGTON STATE: DC ZIP: 20015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS INC CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179326616 MAIL ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 a4.xml 4 X0303 4 2009-03-02 0 0000898437 ANIKA THERAPEUTICS INC ANIK 0001250757 DAVIDSON EUGENE A 32 WIGGINS AVENUE BEDFORD MA 01730 1 0 0 0 Common Stock 2009-03-02 4 M 0 2850 0 A 32850 D Common Stock 2009-03-02 4 A 0 7500 0 A 40350 D These shares (restricted stock units) were granted on February 1, 2008 and were previously reported as restricted stock units in table II on a Form 4 dated February 5, 2008. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in three equal annual installments beginning February 1, 2009. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning March 2, 2010. /s/ Charles H. Sherwood, Attorney-in-Fact 2009-03-03 -----END PRIVACY-ENHANCED MESSAGE-----